| HPVs | Human papillomaviruses |
| CEC | cervical cancer |
| OPC | oropharyngeal cancer |
| ct-DNA | Circulating tumor DNA |
| PCR | polymerase chain reaction |
| ddPCR | digital droplet-based PCR |
| HR | high-risk |
| ISH | in situ hybridization |
| TA-4 | tumor associated antigen 4 (the squamous cell carcinoma antigen) |
| CEA | Carcino Embryonic Antigen |
| TPA | Tissue Polypeptide Antigen |
| TPS | Tissue Polypeptide Specific Antigen |
| CYFRA 21-1 | cytokeratin-19 fragments |
| HNSCC | head and neck squamous cell cancer |
| cf-DNA | cell-free DNA |
| ct-DNA | cell-free tumoral DNA |
| NPC | nasopharyngeal carcinoma |
| HPV ct-DNA | circulating HPV DNA |
| HPV16 ct-DNA | circulating tumor HPV16 DNA |
| AUC | area under the curve |
| dPCR | digital PCR |
| NGS | next generation sequencing |
| TIL | tumor infiltrating lymphocyte therapy |
| EBV | Epstein-Barr Virus |
| ASCC | anal squamous cell carcinoma |
| CNVs | copy number variation |